Condition: Kidney Stones · Sponsor: Icahn School of Medicine at Mount Sinai
This single-center randomized controlled trial at Mount Sinai West will enroll 80 patients undergoing percutaneous nephrolithotomy for calcium oxalate stones. Participants will be randomized to receive either empiric therapy or selective therapy guided by 24-hour urine evaluation. The primary outcome is change in calcium oxalate supersaturation at 4 weeks, aiming to determine whether empiric therapy can provide outcomes comparable to selective therapy while simplifying access to prevention.
This description comes directly from the study's public registry record.
Blair Gallante, MPH · 631-991-1159 · blair.gallante@mountsinai.org
Mantu Gupta, MD · 212-241-1272 · mantu.gupta@mountsinai.org
Always discuss trial participation with your own doctor first.
| Mount Sinai West | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07225764